Abstract
MGuard is an ultra-thin polymer sleeve attached to the external surface stents. The polymer was designed to reduce distal embolization during coronary, renal, carotid, and vein graft stenting, and to potentially serve as a platform for uniform drug delivery. This report discusses the theoretical considerations that resulted in the conception of this device, and the scientific data that support the use of the innovation. With the encouraging initial feasibility and safety data, large-scale efficacy trials are currently in progress. Future applications of this platform for the treatment of cardiovascular disorders are discussed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 88-94 |
| Number of pages | 7 |
| Journal | Cardiovascular Revascularization Medicine |
| Volume | 9 |
| Issue number | 2 |
| DOIs | |
| State | Published - Apr 1 2008 |
| Externally published | Yes |
Keywords
- Emboli protection device
- Stent thrombosis, Restenosis
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint Dive into the research topics of 'Coronary stenting with MGuard: from conception to human trials'. Together they form a unique fingerprint.
Cite this
Kaluski, E., Tsai, S., & Klapholz, M. (2008). Coronary stenting with MGuard: from conception to human trials. Cardiovascular Revascularization Medicine, 9(2), 88-94. https://doi.org/10.1016/j.carrev.2007.12.002